Design and synthesis of bicyclic pyrimidinone-based HCV NS3 protease inhibitors

Peter W Glunz1, Brent D Douty, Carl P Decicco

  • 1Bristol-Myers Squibb Pharmaceutical Research Institute, PO Box 5400, Princeton, NJ 08543-5400, USA. peter.glunz@bms.com